NASDAQ NMS - GLOBAL MARKET · BGLC
+0.79% · +$0.0100 · Vol 11.8K
Live · updated 15:21:39 ET
BioNexus Gene Lab Corp

BioNexus Gene Lab Corp

Trading Companies & Distributors
$1.28
Card
Relationship Map

Follow $BGLC

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BGLC by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · No analyst covers this company
BGLC
BioNexus Gene Lab Corp
Mon Oct 5 · live session · daily score · under 1h old
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Mon Oct 5 · live session · daily score · under 1h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BGLC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BGLC catalysts
About BioNexus Gene Lab Corp
SERVICES-MEDICAL LABORATORIES
Listed since
2020
Employees
1
Country
MY

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.28
Day high
$1.31
Day low
$1.27
Previous close
$1.27
52W high
$5.53
-76.85% from high
52W low
$1.20
2% of range
Market cap
$3.7M
EPS
$-1.0810
Beta
0.36
Shares out
2.9M
Volume
11.8K
1.79× rel vol
Avg volume
6.6K
VWAP
$1.29
Price history computed in-house
1W
-1.54%
1M
-11.72%
3M
-32.98%
1Y
-75.80%
YTD
-67.59%
SMA 50 $1.47 · below
SMA 200 $2.28 · below
52W position 2%

BGLC overview

Loading financial statements
Loading BGLC Form 4 filings
Public disclosures

Congress activity in BGLC

No receipt-qualified filings found.

Federal contracts

BGLC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BGLC in this window.
Lobbying spend

BGLC lobbying filings, year to date.

Registered lobbying filings matched to BioNexus Gene Lab Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BGLC in this window.
Loading news for BGLC
Analyst ratings
Sovereign unlock shows live analyst consensus for BGLC.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.